Immunohistochemical Analysis of Mitochondrial Ferritin in the Midbrain of Patients with Parkinson?s Disease

被引:3
|
作者
Tsubaki, Haruka [1 ]
Yanagisawa, Daijiro [2 ]
Kageyama, Yusuke [3 ,4 ]
Abu Baker, Zulzikry Hafiz [1 ]
Mukaisho, Ken-ichi [3 ,4 ]
Tooyama, Ikuo [1 ,5 ]
机构
[1] Shiga Univ Med Sci, Med Innovat Res Ctr, Otsu, Japan
[2] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Japan
[3] Shiga Univ Med Sci, Dept Pathol, Otsu, Japan
[4] Shiga Univ Med Sci, Educ Ctr Med & Nursing, Otsu, Japan
[5] Shiga Univ Med Sci, Seta Tsukinowa Cho, Otsu 5202192, Japan
基金
日本学术振兴会;
关键词
mitochondrial ferritin; Parkinson?s disease; oxidative stress; mitochondrial dysfunction; neurodegeneration; OXIDATIVE STRESS; CELL-DEATH; FERROPTOSIS; FORM;
D O I
10.1267/ahc.22-00109
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mitochondrial ferritin (FtMt) is an endogenous iron-storage protein localized in the mitochon-dria. FtMt is mainly observed in restricted tissues, such as those in the testis, islets of Langerhans, and brain. Further, it may protect cells from oxidative stress in neurodegenera-tive diseases, including Alzheimer's disease and progressive supranuclear palsy. However, the role of FtMt in Parkinson's disease (PD) remains unclear. Therefore, the current study investigated the localization and expression level of FtMt in the midbrain of patients with PD and healthy controls using immunohistochemical techniques. FtMt immunoreactivity was mainly detected in dopaminergic neurons in the substantia nigra pars compacta (SNc) in both healthy controls and patients with PD. In addition, FtMt-positive particles were observed outside the dopaminergic neurons in patients with PD. Based on a quantitative comparison, patients with PD had a significantly upregulated FtMt immunoreactivity in dopaminergic neu-rons than healthy controls. Our result might be helpful in future studies on the role of FtMt in PD.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 50 条
  • [41] Mitochondrial dysfunction in Parkinson's disease
    Schapira, A. H. V.
    CELL DEATH AND DIFFERENTIATION, 2007, 14 (07): : 1261 - 1266
  • [42] Mitochondrial Biology and Parkinson's Disease
    Perier, Celine
    Vila, Miquel
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (02):
  • [43] MITOCHONDRIAL BIOMARKERS IN PARKINSON'S DISEASE
    Davis, Ryan L.
    Wong, Siew L.
    Carling, Phillipa J.
    Payne, Thomas
    Sue, Carolyn M.
    Bandmann, Oliver
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E47 - E47
  • [44] Mitochondrial Dysfunction in Parkinson's Disease
    Moon, Hyo Eun
    Paek, Sun Ha
    EXPERIMENTAL NEUROBIOLOGY, 2015, 24 (02) : 103 - 116
  • [45] Mitochondrial dynamics in Parkinson's disease
    Van Laar, Victor S.
    Berman, Sarah B.
    EXPERIMENTAL NEUROLOGY, 2009, 218 (02) : 247 - 256
  • [46] Mitochondrial dysfunction in Parkinson's disease
    Greenamyre, JT
    MacKenzie, G
    Peng, TI
    Stephans, SE
    MITOCHONDRIA AND CELL DEATH, 1999, 66 : 85 - 97
  • [47] Mitochondrial Sirtuins in Parkinson’s Disease
    Ling He
    Jihong Wang
    Yazhi Yang
    Jian Li
    Huaijun Tu
    Neurochemical Research, 2022, 47 : 1491 - 1502
  • [48] Mitochondrial involvement in Parkinson's disease
    Orth, M
    Schapira, AHV
    NEUROCHEMISTRY INTERNATIONAL, 2002, 40 (06) : 533 - 541
  • [49] Mitochondrial dysfunction in Parkinson's disease
    A H V Schapira
    Cell Death & Differentiation, 2007, 14 : 1261 - 1266
  • [50] Mitochondrial dysfunctions in Parkinson's disease
    Gautier, C. A.
    Corti, O.
    Brice, A.
    REVUE NEUROLOGIQUE, 2014, 170 (05) : 339 - 343